Nicotine Patch, Gum, and Lozenge: Questions to Discuss with a Clinician

The patch, gum and lozenge have similar long-term quit rates on their own, combining a patch with a fast-acting form beats any single form, and the choice between them depends on questions worth taking to a pharmacist or doctor.

Against placebo or no NRT, the nicotine patch raises long-term quit rates by about 64%, gum by about 49% and lozenges by about 52%, based on a Cochrane review of 133 trials with 64,640 participants [1]. Those numbers look different, but in direct comparisons a fast-acting form and the patch produce similar quit rates, at high certainty [2]. The larger difference is elsewhere: a patch plus gum or lozenge raises quit rates by about 25% over any single form, also at high certainty [2]. The choice is less about which product wins and more about which combination, strength and duration fit the person, and those are the questions where a pharmacist or doctor earns their time.

This post compares the three forms, then lists the questions worth bringing to that conversation. It does not give individualized dosing advice; that depends on your smoking pattern and health history, which is exactly what the clinician is for. For deeper detail on each form, see the posts on how the nicotine patch works, nicotine lozenge vs. gum and combination NRT.

A pharmacy counter with three plain, unlabeled shapes representing a patch, gum and a lozenge beside a notepad

How the three forms differ

All three deliver nicotine without the smoke, which removes the combustion products while easing withdrawal. The mechanism differs in speed.

The patch releases nicotine slowly through the skin over the day. It provides steady background coverage and requires no action once applied. It cannot be used to respond to a sudden craving.

Gum releases nicotine through the lining of the mouth when chewed and then rested against the cheek. It acts faster than the patch and is used in response to cravings or on a schedule. Technique matters, and the package directions describe it; a pharmacist can show you.

The lozenge dissolves slowly in the mouth and also delivers nicotine through the oral lining. It needs no chewing, which suits people with dental work or jaw problems, and is less visible than gum.

CDC guidance lists all three as available over the counter in the US, with the nicotine inhaler and nasal spray available by prescription [3].

The evidence, form by form

The Cochrane review of NRT against placebo or no NRT measured abstinence at six months or longer [1]:

  • Patch: RR 1.64 across 51 trials with 25,754 participants.
  • Gum: RR 1.49 across 56 trials with 22,581 participants.
  • Lozenges and oral tablets: RR 1.52 across 8 trials with 4,439 participants.

The patch figure is slightly higher, but these come from different trials with different populations. When fast-acting forms and the patch were compared directly in 8 studies with 3,319 participants, quit rates were similar (RR 0.90, 95% CI 0.77 to 1.05, high certainty) [2]. The honest summary is that, used alone, the three forms are roughly equivalent.

Combination NRT is where the evidence separates. Across 14 studies with 11,356 participants, a patch combined with a fast-acting form raised quit rates by about 25% compared with a single form (RR 1.25, high certainty) [2]. The benefit held whether the comparison was the patch alone or a fast-acting form alone. CDC guidance makes the same point [3].

Side effects worth raising

The common side effects are local. Patches cause skin irritation at the application site; gum and lozenges cause irritation inside the mouth [1]. Across 15 trials with 11,074 participants, chest pain or palpitations were more frequent with NRT than control (odds ratio 1.88), but the reviewers noted these were rare in both groups, and serious adverse events were extremely rare [1]. Some patch users report vivid dreams or disturbed sleep. The Cochrane dose review compared 16-hour and 24-hour daily patch use and found no clear difference in quit rates [2], so if sleep is affected, it is reasonable to ask whether removing the patch overnight is an option.

People with recent cardiovascular events, those who are pregnant, and those taking medications affected by smoking should have the clinician conversation before starting. It is not a formality in those situations.

Comparison table

MethodSix-month quit rate vs. placeboMechanismMain side effectsPrescription requiredNotes
Nicotine patchRR 1.64 (51 trials)Slow, steady release through the skinSkin irritation; some report sleep disturbanceNo (US)Background coverage; cannot treat sudden cravings
Nicotine gumRR 1.49 (56 trials)Fast-acting, through the lining of the mouthMouth irritation; jaw discomfortNo (US)Chew-and-park technique matters
Nicotine lozengeRR 1.52 (8 trials)Fast-acting, dissolves in the mouthMouth irritationNo (US)No chewing; discreet
Patch plus gum or lozengeRR 1.25 vs. single form (14 studies)Steady base plus fast-acting reliefCombined profile of bothNo (US)High-certainty evidence; underused

The first three rows compare each form with placebo or no NRT; the combination row compares combination with a single form, so the figures are not directly comparable across rows.

Questions to bring to a pharmacist or doctor

These are the questions where the answer depends on you, not on the trials.

Three forms, one conversationSimilar alone, stronger together: what to ask about each form

Nicotine patch

  • RR 1.64 across 51 trials
  • Slow, steady release through the skin
  • Common side effect: skin irritation
  • Ask: which strength fits how soon I smoke after waking?
  • Ask: can I remove it overnight if my sleep is affected?

Nicotine gum

  • RR 1.49 across 56 trials
  • Fast-acting, through the lining of the mouth
  • Common side effect: mouth irritation
  • Ask: is gum practical with my dental work?
  • Ask: how should it fit around a patch?

Nicotine lozenge

  • RR 1.52 across 8 trials
  • Fast-acting, dissolves without chewing
  • Common side effect: mouth irritation
  • Ask: what do I do if I slip and smoke?
  • Ask: what if I need it longer than 8 to 12 weeks?
Quit rates vs. placebo or no NRT at six months or longer (Cochrane, 133 trials). Patch plus a fast-acting form: RR 1.25 vs. a single form, high certainty. Strength and duration are clinician decisions; this is not dosing advice.

About strength. “Given how much I smoke and how soon after waking I have my first cigarette, which strength makes sense?” The Cochrane dose review found the benefit of higher-strength gum may be limited to highly dependent smokers [2], which is why this is an individual conversation rather than a general rule.

About combining. “Should I use a patch and a fast-acting form together, and how should the fast-acting form fit around the patch?” The combination evidence is high certainty [2], and the FDA concluded in 2013 that using more than one OTC NRT product at once does not raise significant safety concerns [4].

About timing. “Should I start before my quit date?” Moderate-certainty Cochrane evidence supports starting NRT before quit day [2], but the right approach depends on the person.

About slips. “If I smoke a cigarette while using NRT, what should I do?” The FDA’s 2013 review found concurrent use with cigarettes does not raise significant safety concerns [4]. Ask the clinician to confirm the plan: keep using NRT and return to not smoking.

About duration. “How long should I use it, and what happens if I need it longer?” Labeled courses are generally 8 to 12 weeks depending on the product, and FDA-allowed labeling says to talk to a health care provider about longer use if you need it to keep from smoking [4].

About your health history. “Does anything in my history, such as heart disease, pregnancy, skin conditions, dental work or other medications, change which form I should use?”

About previous attempts. “I used the patch before and relapsed. Was the dose or duration the issue, or should I consider a prescription option like varenicline?” Varenicline and bupropion require a prescription [3] and are covered in separate posts.

This is a hypothetical scenario, not a real patient. A smoker with dentures who smokes within minutes of waking and has relapsed once on a patch alone brings the list above to a pharmacist. The conversation covers why gum may be impractical with dentures, whether a patch plus lozenge would suit them, and what to do if they slip in the first week. The pharmacist, not the post, sets the plan.

What to bring to the appointment

The conversation goes faster with a few facts written down in advance. Bring how many cigarettes you smoke on a typical day, how soon after waking you have the first one, which quit methods you have tried before and how each attempt ended, a list of your current medications, and any heart, skin, dental or pregnancy considerations. These are the inputs a pharmacist or doctor uses to suggest a strength and combination; without them, the advice is necessarily generic.

Cost is also worth raising. CDC guidance notes that many quit treatments may be free or covered by insurance [3], and the Quitline can sometimes supply NRT directly. Asking about coverage before buying can make combination NRT, which means buying two products, more affordable. If cost is the reason you would choose a single form over a combination, say so; the clinician may know a cheaper route to the higher-efficacy option.

What this means if you’re deciding

If you have never used NRT, the evidence supports starting with a combination of patch and a fast-acting form rather than a single product, with a pharmacist’s input on strength. If you have used one form before and relapsed, the most useful questions are about dose, duration and adding a second form. If you prefer one form for practical reasons, the trials say any of the three alone is a reasonable choice compared with no NRT.

For smokers with COPD, the stakes of choosing well are higher, because quitting is the single most effective intervention for slowing lung function decline; take the question list to your respiratory clinician and see quitting smoking with COPD.

What remains uncertain

The Cochrane comparisons of fast-acting forms against the patch are high certainty, but most dose comparisons are moderate or lower certainty and often rest on few studies [2]. Adverse event reporting varied widely across trials, which limits precise side-effect comparisons between forms [1]. And participants in the dose trials typically smoked at least 15 cigarettes a day [2], so the figures may not transfer exactly to lighter smokers.

A doctor or pharmacist can help choose the right approach for your health history. The Quitline (1-800-QUIT-NOW) provides free coaching and can sometimes supply NRT.

Frequently asked questions

Which works better: nicotine patch, gum or lozenge?

On their own, roughly the same. In a Cochrane review, each raised long-term quit rates against placebo or no NRT: patch RR 1.64 (51 trials), gum RR 1.49 (56 trials), lozenges and oral tablets RR 1.52 (8 trials). Eight head-to-head studies found fast-acting forms and the patch gave similar quit rates (RR 0.90, high certainty). The bigger gain comes from combining a patch with a fast-acting form.

Is combining the patch with gum or a lozenge safe?

In 2013 the FDA concluded that using more than one over-the-counter NRT product at the same time does not raise significant safety concerns and allowed labels to drop the warning against it. A Cochrane review found combination NRT raised quit rates by about 25% over a single form (14 studies, 11,356 participants, high certainty). A clinician can advise on how to combine them for your situation.

What side effects should I ask about?

The patch commonly causes skin irritation at the application site; gum and lozenges commonly cause irritation inside the mouth. Across 15 trials, chest pain or palpitations were more common with NRT than control (odds ratio 1.88) but rare in both groups, and serious adverse events were extremely rare. People with heart disease, or who are pregnant, should discuss NRT with a clinician before starting.

What if I smoke a cigarette while using NRT?

The FDA's 2013 review found that using NRT while also smoking does not raise significant safety concerns, and it allowed the label warning against this to be removed. The practical guidance is to keep using the NRT and return to not smoking. Stopping NRT after a slip removes the withdrawal relief at the moment you most need it.

How long should I use NRT?

Labeled durations are typically 8 to 12 weeks depending on the product. Since 2013, FDA-allowed labeling says to talk to a health care provider if you feel you need NRT for longer to keep from smoking, rather than telling users to stop at the end of the period. How long is right for you is a clinician conversation.

Sources and further reading

  1. Hartmann-Boyce et al. — Nicotine replacement therapy versus control for smoking cessation

    Cochrane Database of Systematic Reviews, 2018;5:CD000146. Systematic review and meta-analysis, 133 trials, 64,640 participants; abstinence at 6+ months, any NRT RR 1.55 (95% CI 1.49-1.61); patch RR 1.64 (1.53-1.75; 51 trials); gum RR 1.49 (1.40-1.60; 56 trials); oral tablets/lozenges RR 1.52 (1.32-1.74; 8 trials); chest pain/palpitations OR 1.88 (1.37-2.57; 15 trials), rare. PMID: 29852054. DOI: 10.1002/14651858.CD000146.pub5

  2. Lindson et al. — Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation

    Cochrane Database of Systematic Reviews, 2019;4:CD013308. Systematic review, 63 trials, 41,509 participants; combination vs. single NRT RR 1.25 (95% CI 1.15-1.36; 14 studies, 11,356 participants; high certainty); fast-acting NRT vs. patch RR 0.90 (0.77-1.05; 8 studies, 3,319 participants; high certainty); higher- vs. lower-dose gum benefit possibly limited to highly dependent smokers; preloading before quit day RR 1.25 (moderate certainty); no clear difference for 16-hour vs. 24-hour patch use; participants typically smoked 15+ cigarettes a day. PMID: 30997928. DOI: 10.1002/14651858.CD013308

  3. Centers for Disease Control and Prevention — How to Quit Smoking

    CDC public guidance. NRT available over the counter as patch, gum or lozenge and by prescription as inhaler or nasal spray; varenicline and bupropion require a prescription; combining a patch with gum or lozenge can increase quit chances vs. one form; many treatments may be free or covered by insurance. Accessed October 2026.

  4. US Food and Drug Administration — Modifications to labeling of nicotine replacement therapy products for over-the-counter human use

    Federal Register, April 2, 2013. FDA review concluded concomitant use of OTC NRT with cigarettes or other nicotine products, including other NRT, does not raise significant safety concerns; labels may advise consulting a health care provider about use beyond the labeled 8-12 week period. Regulatory notice.

Sources checked October 29, 2026. This is an editorial summary, not a systematic review or individual advice.

Get new articles by email

New articles from The Quit Kit, sent to your inbox. Unsubscribe at any time.

Related articles

Choosing a Quit Date and Preparing for It

How to choose a quit smoking date and what to do in the week before it, with the evidence on planned vs. unplanned attempts, abrupt vs. gradual quitting, starting NRT before quit day, and quitline support.

Combination NRT: Why Two Forms Work Better Than One

A review of the evidence for combining nicotine patch with gum or lozenge, including Cochrane data, how it compares to single NRT and varenicline, and why most people still buy only one NRT form.